Johnson & Johnson and its unit Janssen Pharmaceuticals have agreed to settle a lawsuit brought by a Mississippi family that claimed the companies’ antipsychotic drug Risperdal caused their son to develop breasts, a disfiguring condition known as gynecomastia, according to Law360. The announcement came just days before the case was slated to go to trial in Pennsylvania state court. The settlement follows a Superior Court ruling in January during which a global order barring punitive damages on gynecomastia claims with Risperdal in the Philadelphia County Court of Common Pleas was upended. Suddenly faced with the potential of punitive damages, Johnson ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.